Lipidomic Signature of Progression of Chronic Kidney Disease in the Chronic Renal Insufficiency Cohort
2016 · Kidney International Reports · 86 citations
https://doi.org/10.1016/j.ekir.2016.08.007
F
Farsad Afshinnia
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
75
Papers
2.4K
Citations
27
h-index
46
i10-index
Farsad Afshinnia is an academic researcher from University of Michigan–Ann Arbor. The author has contributed to research in topics: Liver Disease Diagnosis and Treatment & Chronic Kidney Disease and Diabetes & Renal Diseases and Glomerulopathies. The author has an h-index of 27, co-authored 64 publications.
ORCID: 0000-0003-3051-3141Papers by this author
worksLow concentrations of medium-sized HDL particles predict incident CVD in chronic kidney disease patients
2023 · Journal of Lipid Research · 10 citations
https://doi.org/10.1016/j.jlr.2023.100381
Supplementary Material for: A Targeted Multiomics Approach to Identify Biomarkers Associated with Rapid eGFR Decline in Type 1 Diabetes
2020 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.13089107
Supplementary Material for: High-Throughput Metabolomics and Diabetic Kidney Disease Progression: Evidence from the Chronic Renal Insufficiency (CRIC) Study
2022 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.19221165
Supplementary Material for: Gut Microbial Product Predicts Cardiovascular Risk in Chronic Kidney Disease Patients
2018 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.7211678
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat